Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRONICA: IV vs Oral Iron in Congestive Heart Failure
NCT07053475Phase 4Terminated
- Start
- Apr 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in heart failure (HF), iron deficiency anemia (IDA). Started Apr 2025; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
heart failure (HF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07053475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07053475.